Hanlin Gao
CIK 1684532 · Chief Scientific Officer · last filed 2026-06-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$18.50M
Companies
1
Total Filings
73
Lifetime Open-Market Net
-$3.62M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| FLGT | Chief Scientific Officer | 990,374 | $18.68 | $18.50M | -$3.62M | 73 | 2026-06-03 |
Recent Filings · Page 7 of 8
73 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-03-02 | FLGT | Grant (A) | +41,000 | $0 | EDGAR |
| 2022-02-17 | FLGT | Tax (F) | −303 | -$20.1K | EDGAR |
| 2021-11-18 | FLGT | Sell (S) | −311 | -$29.7K | EDGAR |
| 2021-08-18 | FLGT | Sell (S) | −314 | -$29.9K | EDGAR |
| 2021-05-20 | FLGT | Sell (S) | −315 | -$22.3K | EDGAR |
| 2021-05-03 | FLGT | Grant (A) | +3,500 | $0 | EDGAR |
| 2021-02-16 | FLGT | Tax (F) | −303 | -$48.8K | EDGAR |
| 2020-11-18 | FLGT | Sell (S) | −301 | -$13.7K | EDGAR |
| 2020-09-15 | FLGT | Other (J) | −467,659 | $0 | EDGAR |
| 2020-08-19 | FLGT | Sell (S) | −1,308 | -$53.8K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.